More MS news articles for September 1999

Immunex Launches Multiple Sclerosis Educational Web Site

Thursday September 16, 11:00 am Eastern Time
Company Press Release
SOURCE: Immunex Corporation
Immunex MS Knowledge Center Offers Personalized Information Resource For People With Multiple Sclerosis, Their Families and Health Care Providers SEATTLE, Sept. 16 /PRNewswire/ -- A new web site,, dedicated to educating people affected by multiple sclerosis (MS) was launched today by Immunex Corporation (Nasdaq: IMNX - news). Developed with input from an advisory board of MS specialists, the multimedia-enhanced site offers comprehensive information on MS, the latest MS news, and feature stories on people living with MS.

The extensive MS Topics section of the site provides in-depth information on a variety of subjects such as "working with your health care team," "dealing with emotional issues" and '`managing personal financial matters.'' Symptom management topics, ranging from bladder and bowel function, to sexuality and skin care are also included.

A special feature of the new Web site will allow patients to tailor the MS Topics section to address issues that are most important to them. By filling out a short Wellness Survey, a personalized Web page will be created that identifies topics that pertain to each patient's needs.

The Profiles of MS section, another unique component of the Web site, features stories of people who are pushing the boundaries of living with MS. The first featured profile is of a modern dancer and choreographer living with MS. Diagnosed in 1987, she has adapted to MS by incorporating the disease into her choreography.

Multiple sclerosis is a chronic, debilitating disease of the central nervous system that, in its various stages, afflicts as many as 350,000 people in the United States. The symptoms of MS result when a breakdown occurs in the myelin sheath, the fatty substance that insulates the nerve fibers of the brain and spinal cord. This demyelination process causes patches of scar tissue, or "sclerosis," which interfere with the nerves' ability to transport messages from the brain to body parts. This can result in a variety of symptoms that range from numbness in the limbs to complete paralysis.

Immunex Corporation is a biopharmaceutical company dedicated to developing immune system science to protect human health. The company's products offer hope to patients with cancer, inflammatory and infectious diseases.

American Home Products Corporation owns a majority interest in Immunex. AHPC is one of the world's largest research-based pharmaceutical and health care products companies and is a leading developer, manufacturer and marketer of prescription drugs and over-the-counter medications. It is also a leader in vaccines, biotechnology, agricultural products and animal health care.

This news release contains forward-looking statements that involve risks and uncertainties, including risks associated with clinical development, regulatory approvals, product commercialization and other risks described from time to time in the SEC reports filed by Immunex, including the most recently filed Form 10-Q.

An electronic version of this news release -- as well as additional information about Immunex of interest to investors, customers, future employees and patients -- is available on the Immunex home page at

SOURCE: Immunex Corporation